Literature DB >> 23498238

Development, characterisation and biocompatibility testing of a cobalt-containing titanium phosphate-based glass for engineering of vascularized hard tissues.

In-Ho Lee1, Hye-sun Yu, Nilay J Lakhkar, Hae-Won Kim, Myoung-Seon Gong, Jonathan C Knowles, Ivan B Wall.   

Abstract

There is a continuing need to develop scaffold materials that can promote vascularisation throughout the tissue engineered construct. This study investigated the effect of cobalt oxide (CoO) doped into titanium phosphate glasses on material properties, biocompatibility and vascular endothelial growth factor (VEGF) secretion by osteoblastic MG63 cells. Glasses composed of (P2O5)45(Na2O)20(TiO2)05(CaO)30-x(CoO)x(x=0, 5, 10, and 15 mol%) were fabricated and the effect of Co on physicochemical properties including density, glass transition temperature (Tg), degradation rate, ion release, and pH changes was assessed. The results showed that incorporation of CoO into the glass system produced an increase in density with little change in Tg. It was then confirmed that the pH did not change significantly when CoO was incorporated in the glass, and stayed constant at around 6.5-7.0 throughout the dissolution study period of 336 h. Ion release results followed a specific pattern with increasing amounts of CoO. In general, although incorporation of CoO into a titanium phosphate glass increased its density, other bulk and surface properties of the glass did not show any significant changes. Cell culture studies performed using MG63 cells over a 7-day period indicated that the glasses provide a stable surface for cell attachment and are biocompatible. Furthermore, VEGF secretion was significantly enhanced on all glasses compared with standard tissue culture plastic and Co doping enhanced this effect further. In conclusion, the developed Co-doped glasses are stable and biocompatible and thus offer enhanced potential for engineering vascularized tissue. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23498238     DOI: 10.1016/j.msec.2013.01.024

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

Review 1.  Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue.

Authors:  Jacob P Mertens; Kristoffer B Sugg; Jonah D Lee; Lisa M Larkin
Journal:  Regen Med       Date:  2014-01       Impact factor: 3.806

Review 2.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

3.  Strontium- and calcium-containing, titanium-stabilised phosphate-based glasses with prolonged degradation for orthopaedic tissue engineering.

Authors:  Mustafa Al Qaysi; Nick J Walters; Farzad Foroutan; Gareth J Owens; Hae-Won Kim; Rishma Shah; Jonathan C Knowles
Journal:  J Biomater Appl       Date:  2015-05-28       Impact factor: 2.646

4.  Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications.

Authors:  Ross Colquhoun; Nikolaj Gadegaard; David M Healy; K Elizabeth Tanner
Journal:  J Mater Sci Mater Med       Date:  2016-08-31       Impact factor: 3.896

5.  Characterisation of osteogenic and vascular responses of hMSCs to Ti-Co doped phosphate glass microspheres using a microfluidic perfusion platform.

Authors:  Carlotta Peticone; David De Silva Thompson; Nikolay Dimov; Ben Jevans; Nick Glass; Martina Micheletti; Jonathan C Knowles; Hae-Won Kim; Justin J Cooper-White; Ivan B Wall
Journal:  J Tissue Eng       Date:  2020-10-24       Impact factor: 7.813

6.  Microstructure and Defect-Based Fatigue Mechanism Evaluation of Brazed Coaxial Ti/Al2O3 Joints for Enhanced Endoprosthesis Design.

Authors:  Johannes L Otto; Ivan Fedotov; Milena Penyaz; Thorge Schaum; Anke Kalenborn; Boris Kalin; Oleg Sevryukov; Frank Walther
Journal:  Materials (Basel)       Date:  2021-12-20       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.